Patients 3 ways to make 2024 the year of the patient Clinical research is never just about the next year; it's always about the next several years.
Digital Retaining the human element of AI within pharma and healthca... Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?
Partner Content Partner Content The ryze-elluminate integration to maximise automation in cl... The ryze-elluminate integration
News Regeneron's three-monthly gMG drug Livsayis cleared by FDA Regeneron has joined the crowded gMG market with an siRNA-based therapy, Livsayis, that only needs to be dosed four times a year.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.